Jinghua Pharmaceutical Group Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinghua Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Porton Pharma Solutions Ltd
sales of 1.18 billion Chinese Renmimbi [US$172.20 million]
of which 83%
was Pharmaceutical R&D Production),
Jilin Jian Yisheng Pharmaceutical Company Limited
(1.03 billion Chinese Renmimbi [US$150.44 million]
of which 68%
was Pharmaceutical), and
Tibet Cheezheng Tibetan Medicine Co Ltd
(1.05 billion Chinese Renmimbi [US$153.16 million]
of which 100%
was Pharmaceutical industry).
Jinghua Pharmaceutical Group Co Ltd reported sales of 1.12 billion Chinese Renmimbi (US$163.02 million)
December of 2017.
increase of 27.2%
versus 2016, when the company's sales were 881.32 million Chinese Renmimbi.
This was the third consecutive year of growth at Jinghua Pharmaceutical Group Co Ltd.